State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship
- 24 August 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Oncology Reports
- Vol. 12 (6), 366-373
- https://doi.org/10.1007/s11912-010-0123-2
Abstract
The prognosis of Hodgkin’s lymphoma (HL) has markedly improved as management strategies evolved. In the modern era, less than 15% of patients with early-stage, non-bulky HL will relapse, and less than one third of those with advanced disease will relapse. As therapy for HL intensified, and as disease-related outcomes improved, the impact of the late effects of therapy has become increasingly important. There is a growing body of literature describing the late morbidity experienced by survivors of HL, including risks of second primary malignancy, cardiac disease, pulmonary disease, and endocrine dysfunction. Additionally, the impact of disease and treatment on psychosocial function and quality of life has been a subject of investigation, with survivors often suffering from impairment. An understanding of these risks and the management implications inherent to them is central to the care of survivors of HL.Keywords
This publication has 65 references indexed in Scilit:
- Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trialThe Lancet Oncology, 2009
- Preserving female fertility following cancer treatment: Current options and future possibilitiesPediatric Blood & Cancer, 2009
- Preservation of Fertility in Patients with CancerThe New England Journal of Medicine, 2009
- American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late EffectsJournal of Clinical Oncology, 2007
- Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: A population-based studyEuropean Journal of Cancer, 2006
- Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 PatientsJNCI Journal of the National Cancer Institute, 2006
- Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsBlood, 2002
- Comparison of psychosocial adaptation and sexual function of survivors of advanced hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVDCancer, 1992
- Hodgkin disease survivors at increased risk for problems in psychosocial adaptationCancer, 1992
- Leukemia Following Hodgkin's DiseaseThe New England Journal of Medicine, 1990